Postes actifs de Rein Ulijn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Renephra Ltd.
 Renephra Ltd. Miscellaneous Commercial ServicesCommercial Services Renephra Ltd. develops medical devices. Its is developing ground-breaking new approaches to dialysis treatment in end-stage renal disease by accessing the interstitial fluid in the skin. This new approach enables water and toxin removal in a non-invasive manner. The company was founded by Paul Brenchley and Sandip Mitra in 2009 and is headquartered in Manchester, the United Kingdom. | Directeur Technique/Scientifique/R&D | - | - |
| Fondateur | - | - |
Historique de carrière de Rein Ulijn
Anciens postes connus de Rein Ulijn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biogelx Ltd.
 Biogelx Ltd. Pharmaceuticals: MajorHealth Technology Biogelx Ltd. is a British company that manufactures and distributes peptide hydrogels. The company is based in Newhouse, UK. The company was founded in 2013 by Rein Ulijn. Alison Gibson Boyd Clayton has been the CEO of the company since 2020. | Directeur Technique/Scientifique/R&D | 01/01/2013 | - |
| Fondateur | 01/01/2013 | - |
Statistiques
Internationale
| Royaume-Uni | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sectorielle
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Renephra Ltd.
Renephra Ltd. Miscellaneous Commercial ServicesCommercial Services Renephra Ltd. develops medical devices. Its is developing ground-breaking new approaches to dialysis treatment in end-stage renal disease by accessing the interstitial fluid in the skin. This new approach enables water and toxin removal in a non-invasive manner. The company was founded by Paul Brenchley and Sandip Mitra in 2009 and is headquartered in Manchester, the United Kingdom. | Commercial Services |
Biogelx Ltd.
Biogelx Ltd. Pharmaceuticals: MajorHealth Technology Biogelx Ltd. is a British company that manufactures and distributes peptide hydrogels. The company is based in Newhouse, UK. The company was founded in 2013 by Rein Ulijn. Alison Gibson Boyd Clayton has been the CEO of the company since 2020. | Health Technology |
- Bourse
- Insiders
- Rein Ulijn
- Expérience
